Ming Zhang, Chunsheng Dong, & Sidong Xiong. (2017). Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMing Zhang, Chunsheng Dong, and Sidong Xiong. Heterologous Boosting with Recombinant VSV-846 in BCG-primed Mice Confers Improved Protection Against Mycobacterium Infection. Taylor & Francis Group, 2017.
MLA (9th ed.) CitationMing Zhang, et al. Heterologous Boosting with Recombinant VSV-846 in BCG-primed Mice Confers Improved Protection Against Mycobacterium Infection. Taylor & Francis Group, 2017.
Warning: These citations may not always be 100% accurate.